Artisan Partners Limited Partnership Exact Sciences Corp Transaction History

Artisan Partners Limited Partnership

$63.7 Billion
Q3 2024

A detailed history of Artisan Partners Limited Partnership transactions in Exact Sciences Corp stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 3,814,526 shares of EXAS stock, worth $214 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

3,814,526

Previous 3,805,389 0.24%

Holding current value

$214 Million

Previous $161 Million 61.55%

% of portfolio

0.41%

Previous 0.25%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$42.43 - $70.83 $387,682 - $647,173	9,137 Added 0.24%	3,814,526 $260 Million
Q2 2024 Aug 12, 2024	BUY	$41.33 - $74.26 $28.7 Million - $51.5 Million	693,458 Added 22.28%	3,805,389 $161 Million
Q1 2024 May 13, 2024	SELL	$56.27 - $73.77 $76.4 Million - $100 Million	-1,358,347 Reduced 30.39%	3,111,931 $215 Million
Q4 2023 Feb 12, 2024	BUY	$59.06 - $75.72 $30 Million - $38.5 Million	508,764 Added 12.84%	4,470,278 $331 Million
Q3 2023 Nov 09, 2023	BUY	$65.94 - $99.04 $27.6 Million - $41.5 Million	418,770 Added 11.82%	3,961,514 $270 Million
Q2 2023 Aug 10, 2023	BUY	$62.68 - $95.05 $53.6 Million - $81.3 Million	855,418 Added 31.83%	3,542,744 $333 Million
Q1 2023 May 11, 2023	BUY	$47.19 - $70.77 $24.4 Million - $36.5 Million	516,233 Added 23.78%	2,687,326 $182 Million
Q4 2022 Feb 10, 2023	BUY	$30.35 - $53.15 $33.6 Million - $58.9 Million	1,107,474 Added 104.12%	2,171,093 $107 Million
Q3 2022 Nov 10, 2022	BUY	$31.97 - $49.37 $130,661 - $201,775	4,087 Added 0.39%	1,063,619 $34.6 Million
Q2 2022 Aug 12, 2022	SELL	$35.61 - $76.23 $571,682 - $1.22 Million	-16,054 Reduced 1.49%	1,059,532 $41.7 Million
Q1 2022 May 13, 2022	BUY	$57.56 - $82.54 $708,851 - $1.02 Million	12,315 Added 1.16%	1,075,586 $75.2 Million
Q4 2021 Feb 11, 2022	SELL	$72.5 - $100.68 $44 Million - $61.2 Million	-607,432 Reduced 36.36%	1,063,271 $82.8 Million
Q3 2021 Nov 12, 2021	SELL	$90.24 - $124.05 $79.9 Million - $110 Million	-885,258 Reduced 34.64%	1,670,703 $159 Million
Q2 2021 Aug 12, 2021	SELL	$93.66 - $139.27 $13.6 Million - $20.3 Million	-145,708 Reduced 5.39%	2,555,961 $318 Million
Q1 2021 May 11, 2021	SELL	$116.57 - $155.01 $57.6 Million - $76.6 Million	-494,188 Reduced 15.46%	2,701,669 $356 Million
Q4 2020 Feb 10, 2021	BUY	$99.61 - $142.12 $21.5 Million - $30.6 Million	215,604 Added 7.23%	3,195,857 $423 Million
Q3 2020 Nov 12, 2020	BUY	$72.92 - $102.01 $30.5 Million - $42.6 Million	417,778 Added 16.3%	2,980,253 $304 Million
Q2 2020 Aug 12, 2020	BUY	$55.75 - $92.75 $12.3 Million - $20.4 Million	219,919 Added 9.39%	2,562,475 $223 Million
Q1 2020 May 12, 2020	BUY	$37.9 - $104.44 $5.72 Million - $15.8 Million	150,842 Added 6.88%	2,342,556 $136 Million
Q4 2019 Feb 12, 2020	BUY	$77.66 - $99.74 $29.2 Million - $37.5 Million	375,796 Added 20.69%	2,191,714 $203 Million
Q3 2019 Nov 12, 2019	BUY	$90.37 - $122.49 $4.33 Million - $5.87 Million	47,952 Added 2.71%	1,815,918 $164 Million
Q2 2019 Aug 09, 2019	SELL	$89.51 - $118.04 $3.86 Million - $5.09 Million	-43,162 Reduced 2.38%	1,767,966 $209 Million
Q1 2019 May 10, 2019	SELL	$61.98 - $96.5 $3.18 Million - $4.96 Million	-51,375 Reduced 2.76%	1,811,128 $157 Million
Q4 2018 Feb 12, 2019	SELL	$56.04 - $82.66 $12.1 Million - $17.9 Million	-216,406 Reduced 10.41%	1,862,503 $118 Million
Q3 2018 Nov 13, 2018	BUY	$48.29 - $80.6 $9.63 Million - $16.1 Million	199,384 Added 10.61%	2,078,909 $164 Million
Q2 2018 Aug 10, 2018	BUY	$37.84 - $69.96 $14.6 Million - $27 Million	385,766 Added 25.83%	1,879,525 $112 Million
Q1 2018 May 10, 2018	BUY	$39.82 - $57.53 $59.5 Million - $85.9 Million	1,493,759 New	1,493,759 $60.2 Million

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.93B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.

Account

Artisan Partners Limited Partnership Exact Sciences Corp Transaction History